About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
Save As PDF Print this page

USITC Notices

R-134A Will Face AD/CV Duties
The USITC has issued a final affirmative injury determination in its AD and CV investigations of 1,1,1,2-tetrafluoroethane (R-134a) from mainland China. As a result, the DOC will issue AD and CV duty orders on imports of subject merchandise. Such imports will not be subject to retroactive AD/CV duties in light of the USITC’s negative finding of critical circumstances.

Scheduling of Preliminary Phase of AD/CV Injury Probes of Aluminium Foil
The USITC has scheduled the preliminary phase of its AD and CV injury investigations of aluminium foil from mainland China. The conference will be held on 30 March and written submissions are due by 4 April. The USITC’s preliminary injury vote is expected to take place on 21 April.

AD Duty Order on Pure Magnesium Renewed
The USITC has issued a final affirmative injury determination in its sunset review of the AD duty order on pure magnesium (ingot) from mainland China. As a result, this order will be extended for another five years.

Section 337 Probes of Mobile Electronic Devices, Mobile Device Holders and Sweeteners Terminated
The USITC has terminated without the imposition of import restrictions its Section 337 patent infringement investigations of certain mainland Chinese (1) mobile electronic devices, (2) mobile device holders and components thereof, and (3) high-potency sweeteners, processes for making same and products containing same. The first proceeding was ended based upon a settlement agreement between the complainant and the respondents. The second investigation was terminated with respect to one respondent based on a settlement agreement with the complainant, while the third investigation was rescinded based on the withdrawal of the complaint.

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)